NLRP3 and colitis: In conclusion, these results suggest that the NLRP3 inflammasome may have a protective effect on Th2 cytokines- and immune system-mediated experimental colitis; both the inflammasome derived IL-1β and IL-18 contribute to this protection via different mechanisms.